PharmiWeb

Ophthalmology Drugs Market Analysis by Key Drivers, Top Players, Forecast, Growth Rate, Constraints, Future Trends, Events, And Challenges Until 2030

Global Ophthalmology Drugs Market OutlookThe global ophthalmology drugs market is forecasted to expand at a CAGR of nearly 8% over the next several years, driven by the rising burden of vision ...
Endocrinology Advisor

Faricimab Upholds, Improves Visual Acuity With Fewer Injections in DME

In diabetic macular edema, faricimab can improve visual acuity for treatment-naïve eyes or sustain vision for those ...
Ophthalmology Advisor

Anti-VEGF Reduces Myopia Odds in ROP, But Comes With Higher Risks

Anti-VEGF therapy for patients with retinopathy of prematurity reduces myopia compared with laser treatments, but comes with other risks.
Center for Biosimilars

Biosimilar QL1207 Demonstrates Equivalent Efficacy and Safety in DME

The Center for Biosimilars connects professionals with insights on biosimilars, health economics, regulatory outcomes, and ...
IEEE

Diabetic Retinopathy Detection in Fundus Images Using Deep-Learned Features

Abstract: Diabetic Retinopathy (DR) is a condition that is marked by deterioration of retinal blood vessels due to diabetes, serving as a primary factor for vision impairment. Diabetic Macular Edema ...
IEEE

An Insight on the Timely Diagnosis of Diabetic Retinopathy Using Traditional and AI-Driven Approaches

Abstract: Diabetic Retinopathy is a progressive microvascular complication of diabetes that requires early detection to improve patient outcomes. Traditional screening techniques, including fundus ...
Center for Biosimilars

Swiss Analysis Shows Biosimilars Cut Costs but Longer-Interval Options Lead Savings

Explore the cost-effectiveness of ranibizumab biosimilars versus aflibercept in treating AMD and DME, revealing significant ...